CRSPNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
CRISPR Therapeutics AG
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$50.04+0.79 (+1.60%)
Close on Oct 19, 2026
- Market cap
- $4.83B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of CRISPR Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 19, 2026 | Oct 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 11, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2025 | Oct 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 16, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 26, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 11, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2024 | Nov 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 5, 2024 | SEC EDGAR |
| Current report | 8-K | May 30, 2024 | Jun 3, 2024 | SEC EDGAR |
| Current report | 8-K | May 23, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 30, 2024 | Apr 9, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 21, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2024 | Feb 21, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2024 | Feb 13, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2024 | Feb 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 16, 2024 | Jan 16, 2024 | SEC EDGAR |